Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.

Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Hikiba Y, Obi S, Goto T, Kang YJ, Maeda S, Yoshida H, Omata M, Asahara H, Koike K.

Hepatology. 2013 Jan;57(1):162-70. doi: 10.1002/hep.26011.

2.

A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function.

Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Kudo Y, Goto T, Yoshida H, Koike K.

Biochem Biophys Res Commun. 2012 Apr 13;420(3):564-9. doi: 10.1016/j.bbrc.2012.03.034. Epub 2012 Mar 16.

PMID:
22445758
3.

NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.

Bao C, Li Y, Huan L, Zhang Y, Zhao F, Wang Q, Liang L, Ding J, Liu L, Chen T, Li J, Yao M, Huang S, He X.

Sci Signal. 2015 Jul 28;8(387):ra75. doi: 10.1126/scisignal.aaa8441.

PMID:
26221053
4.

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.

Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K, Jacob ST.

Hepatology. 2009 Oct;50(4):1152-61. doi: 10.1002/hep.23100.

5.
6.

miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.

Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z.

Cell Signal. 2013 Feb;25(2):439-46. doi: 10.1016/j.cellsig.2012.10.013. Epub 2012 Nov 1.

PMID:
23124077
7.

miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells.

Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, Thirion M, Kosaka N, Takahashi RU, Shibata T, Miyajima A, Ochiya T.

Hepatology. 2013 Sep;58(3):1153-65. doi: 10.1002/hep.26422. Epub 2013 Jul 30.

PMID:
23532995
8.

High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.

Chen W, Zhou P, Li X.

Int J Mol Med. 2016 Jun;37(6):1551-7. doi: 10.3892/ijmm.2016.2575. Epub 2016 Apr 25.

9.

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).

Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X.

Oncogene. 2012 Aug 2;31(31):3607-20. doi: 10.1038/onc.2011.523. Epub 2011 Nov 21.

PMID:
22105365
10.

MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.

Zhang L, Yang L, Liu X, Chen W, Chang L, Chen L, Loera S, Chu P, Huang WC, Liu YR, Yen Y.

Hepatology. 2013 May;57(5):1919-30. doi: 10.1002/hep.26162. Epub 2013 Apr 5.

PMID:
23175432
11.

MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.

Long XR, He Y, Huang C, Li J.

Int J Oncol. 2014 Jun;44(6):1915-22. doi: 10.3892/ijo.2014.2373. Epub 2014 Apr 8.

PMID:
24714841
12.
13.

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.

Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM.

Mol Cancer. 2014 Feb 24;13:35. doi: 10.1186/1476-4598-13-35.

14.

Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis.

Kwon HJ, Won YS, Suh HW, Jeon JH, Shao Y, Yoon SR, Chung JW, Kim TD, Kim HM, Nam KH, Yoon WK, Kim DG, Kim JH, Kim YS, Kim DY, Kim HC, Choi I.

J Immunol. 2010 Oct 1;185(7):3980-9. doi: 10.4049/jimmunol.1000990. Epub 2010 Sep 8.

15.

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.

Zhang X, Liu S, Hu T, Liu S, He Y, Sun S.

Hepatology. 2009 Aug;50(2):490-9. doi: 10.1002/hep.23008.

PMID:
19472311
16.

Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.

Sunami Y, Ringelhan M, Kokai E, Lu M, O'Connor T, Lorentzen A, Weber A, Rodewald AK, Müllhaupt B, Terracciano L, Gul S, Wissel S, Leithäuser F, Krappmann D, Riedl P, Hartmann D, Schirmbeck R, Strnad P, Hüser N, Kleeff J, Friess H, Schmid RM, Geisler F, Wirth T, Heikenwalder M.

Hepatology. 2016 May;63(5):1592-607. doi: 10.1002/hep.28435. Epub 2016 Mar 4.

PMID:
26892811
17.

S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.

Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M, Ben-Neriah Y, Pikarsky E, Angel P, Hess J.

Hepatology. 2009 Oct;50(4):1251-62. doi: 10.1002/hep.23099.

PMID:
19670424
18.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
19.

miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.

Zhao L, Zhang Y.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):370-7. doi: 10.1016/j.bbrc.2014.12.119. Epub 2015 Jan 9.

PMID:
25580008
20.

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.

Tanic M, Zajac M, Gómez-López G, Benítez J, Martínez-Delgado B.

Breast Cancer Res Treat. 2012 Jul;134(1):41-51. doi: 10.1007/s10549-011-1905-4. Epub 2011 Dec 14.

PMID:
22167321

Supplemental Content

Support Center